UK markets open in 4 hours 40 minutes
NIKKEI 225
38,344.45 +270.47 (+0.71%) HANG SENG
18,678.23 +140.42 (+0.76%) CRUDE OIL
79.68 +0.42 (+0.53%) GOLD FUTURES
2,358.30 +18.00 (+0.77%) DOW
39,387.76 +331.36 (+0.85%) Bitcoin GBP
50,194.90 +1,023.93 (+2.08%)
Amicus Therapeutics, Inc. (0HF9.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:39PM BST
| Previous close | 10.29 |
| Open | 0.00 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 814 |
| Market cap | 27.496M |
| Beta (5Y monthly) | 0.79 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Amicus Therapeutics (FOLD) Reports Q1 Loss, Lags Revenue Estimates
Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of 66.67% and 1.09%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Zacks
ANI Pharmaceuticals (ANIP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.